ONYX PHARMACEUTICALS INC
ONXX
ONXX was delisted on the 30th of September, 2013.
258 hedge funds and large institutions have $7.38B invested in ONYX PHARMACEUTICALS INC in 2013 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 54 increasing their positions, 104 reducing their positions, and 95 closing their positions.
283% more funds holding in top 10
Funds holding in top 10: 12 → 46 (+34)
55% more call options, than puts
Call options by funds: $1.26B | Put options by funds: $810M
5% less funds holding
Funds holding: 272 → 258 (-14)
13% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 95
20% less capital invested
Capital invested by funds: $9.18B → $7.38B (-$1.8B)
48% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 104
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
+$399M |
| 2 |
HI
HBK Investments
Dallas,
Texas
|
+$344M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$336M |
| 4 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$250M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$248M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.39B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.22B |
| 3 |
JP Morgan Chase
New York
|
-$736M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$580M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$331M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NES
351
New England Securities
New York
| – | -$4K | -48 | Closed |
|
352
Bessemer Group
Woodbridge,
New Jersey
| – | -$3K | -33 | Closed |
|
|
PTC
353
Private Trust Company
Cleveland,
Ohio
| – | -$2K | -18 | Closed |
|
ONXX Hedge Fund Activity: Q3 2013 in Review
258 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in ONYX PHARMACEUTICALS INC (ONXX) for Q3 2013, worth a combined $7.38B — down 20% from $9.18B a quarter earlier.
Sellers outnumbered buyers: 95 funds closed out of ONXX and 83 opened new positions — a net loss of 12 holders — while 104 trimmed existing stakes and 54 added.
The largest buyer was Davidson Kempner Capital Management, opening a new position worth an estimated $399M. The largest seller was BNP Paribas Financial Markets, cutting an estimated $1.39B.
- 258 institutional investors held ONYX PHARMACEUTICALS INC (ONXX) as of Q3 2013, down from 272 in Q2 2013.
- Funds reported $7.38B of ONYX PHARMACEUTICALS INC stock for Q3 2013, down 20% quarter-over-quarter.
- 83 funds opened new ONYX PHARMACEUTICALS INC positions in Q3 2013 and 95 closed out, a net change of -12 holders.
- The largest ONYX PHARMACEUTICALS INC buyer in Q3 2013 was Davidson Kempner Capital Management, an estimated $399M added.
- The largest ONYX PHARMACEUTICALS INC seller in Q3 2013 was BNP Paribas Financial Markets, an estimated $1.39B sold.
Based on aggregated 13F filings for Q3 2013.